Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Effectiveness and Safety of Hetrombopag-Containing Therapy in Patients with Severe Aplastic Anemia: A Multicenter Real-World Study

Hong Chang, Ling Pan, Yongqian Jia, Bing Xiang, Xiaoou Huang, Yong Guo, Meng Li, Hongyun Xing, Fang Xu, Ying Yuan, Ying Lian, Lihua Yang, Ting Niu

Blood (2023) 142 (Supplement 1): 5631.

https://doi.org/10.1182/blood-2023-185469

Published: 2023

Journal Articles

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

Blood (2016) 128 (22): 4882.

https://doi.org/10.1182/blood.V128.22.4882.4882

Published: 2016

Journal Articles

Combination Imatinib with Interferon-α For Philadelphia Positive Acute Lymphocytic Leukemia: A Mutiple Centers Study In China

Pu Kuang, MD, PhD, Yu Wu, MD, PhD, Bing Xiang, MD, Hongbing Ma, MD, Hong Chang, MD, Ting Niu, MD, PhD, Xu Cui, MD, Chuan He, MD, Jianjun Li, MD, Jie Ji, MD, Jie Huang, MD, Tian Dong, MD, PhD, Qing Shenglan, MB, Huaxin Wu, MB, Xiaogong Liang, MSc, Haiying Guo, MB, Chunnong Wu, MB, Ting Liu, MD

Blood (2013) 122 (21): 5019.

https://doi.org/10.1182/blood.V122.21.5019.5019

Published: 2013

Journal Articles

An Escalated Dose of Bortezomib Plus Second Line Chemotherapy for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,

Yongqian Jia, MD, Bing Xiang, MD, Xiaodong Wang, MD, Jianjun Li, MD, Chuan He, MD, Yi Su, MD, Hong Lu, MD, Ting Niu, MD, Jie Huang, MD, Xinchuan Chen, MD, Xu Cui, MD, Yuping Gong, MD, PhD, Huanling Zhu, MD, Ting Liu, MD

Blood (2011) 118 (21): 3714.

https://doi.org/10.1182/blood.V118.21.3714.3714

Published: 2011

Journal Articles

Imatinib 400mg Daily Combined with Vindesine and Dexamethasone As Induction and Maintenance Therapy for Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

Ting Liu, MD, Pu Kuang, MD, Tian Dong, MD, Bing Xiang, MD, Jianjun Li, MD, Xinchuan Chen, MD, Chuan He, MD, Hongbing Ma, MD, Jie Ji, MD, Yuping Gong, MD, PhD, Hong Chang, MD, Yu Wu, MD, PhD, Huanling Zhu, MD, Yuchun Wang, MD, PhD

Blood (2011) 118 (21): 4243.

https://doi.org/10.1182/blood.V118.21.4243.4243

Published: 2011

Journal Articles

Experience with Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Study of 56 Patients in a Single Institute of China

Xiao Shuai, MD, Ting Liu, MD, Ting Niu, MD, Hong Chang, MD, Jianjun Li, MD, Jie Huang, MD, Xu Cui, MD, Jie Ji, MD, Hongbing Ma, MD, Bing Xiang, MD, Chuan He, MD, Yu Wu, MD, PhD, Yuping Gong, MD, PhD

Blood (2011) 118 (21): 4727.

https://doi.org/10.1182/blood.V118.21.4727.4727

Published: 2011

Journal Articles

Gemcitabine, L-Asparaginase, Ifosfamide, Dexamethasone and Etoposide (GLIDE) Regiment In Advanced or Refractory Aggressive NK/T Cell Lymphomas: A Pilot Study

Jie Ji, MD, Ting Liu, MD, Bing Xiang, MD, Yongqian Jia, MD

Blood (2011) 118 (21): 5208.

https://doi.org/10.1182/blood.V118.21.5208.5208

Published: 2011

Journal Articles

Outcome with Hyper-CVAD/MTX-Ara-C, a Dose-Intensive Regimen, in Acute Lymphocytic Leukemia and Highly Aggressive Lymphoma in China.

Ting Niu, MD, PhD, Ting Liu, M.D., Bing Xiang, M.D., Hong Chang, M.D., Yong-qian Jia, M.D., Huan-ling Zhu, M.D.

Blood (2007) 110 (11): 4328.

https://doi.org/10.1182/blood.V110.11.4328.4328

Published: 2007

Journal Articles

Homoharringtonine and Low-Dose Cytosine Arabinoside Combined with G-CSF or GM-CSF Administered in Patients with Advanced Myelodysplastic Syndromes and Relapsed or Refractory Acute Myeloid Leukemia.

Caigang Xu, MD, Juan Xu, M.D, Ting Liu, M.D, Bing Xiang, M.D, Hong Chang, M.D, Chuan He, M.D

Blood (2007) 110 (11): 1465.

https://doi.org/10.1182/blood.V110.11.1465.1465

Published: 2007

Journal Articles

Outcome with Hyper-CVAD/MTX-Ara-C, a Dose-Intensive Regimen, in Acute Lymphocytic Leukemia and Highly Aggressive Lymphoma: A Preliminary Study in a Single Center in China.

Ting Niu, MD, PhD, Ting Liu, M.D., Bing Xiang, M.D., Hong Chang, M.D., Yong-qian Jia, M.D., Huan-ling Zhu, M.D.

Blood (2006) 108 (11): 4529.

https://doi.org/10.1182/blood.V108.11.4529.4529

Published: 2006

NARROW

Effectiveness and Safety of Hetrombopag-Containing Therapy in Patients with Severe Aplastic Anemia: A Multicenter Real-World Study

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

Combination Imatinib with Interferon-α For Philadelphia Positive Acute Lymphocytic Leukemia: A Mutiple Centers Study In China

An Escalated Dose of Bortezomib Plus Second Line Chemotherapy for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,

Imatinib 400mg Daily Combined with Vindesine and Dexamethasone As Induction and Maintenance Therapy for Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

Experience with Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Study of 56 Patients in a Single Institute of China

Gemcitabine, L-Asparaginase, Ifosfamide, Dexamethasone and Etoposide (GLIDE) Regiment In Advanced or Refractory Aggressive NK/T Cell Lymphomas: A Pilot Study

Outcome with Hyper-CVAD/MTX-Ara-C, a Dose-Intensive Regimen, in Acute Lymphocytic Leukemia and Highly Aggressive Lymphoma in China.

Homoharringtonine and Low-Dose Cytosine Arabinoside Combined with G-CSF or GM-CSF Administered in Patients with Advanced Myelodysplastic Syndromes and Relapsed or Refractory Acute Myeloid Leukemia.

Outcome with Hyper-CVAD/MTX-Ara-C, a Dose-Intensive Regimen, in Acute Lymphocytic Leukemia and Highly Aggressive Lymphoma: A Preliminary Study in a Single Center in China.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only